Suppr超能文献

普拉德-威利综合征行为特征的临床管理。

Clinical management of behavioral characteristics of Prader-Willi syndrome.

机构信息

Department of Psychology, Case Western Reserve University, Cleveland, OH, USA.

出版信息

Neuropsychiatr Dis Treat. 2010 May 6;6:107-18. doi: 10.2147/ndt.s5560.

Abstract

Prader-Willi syndrome (PWS) is a complex neurodevelopmental disorder caused by an abnormality on the long arm of chromosome 15 (q11-q13) that results in a host of phenotypic characteristics, dominated primarily by hyperphagia and insatiable appetite. Characteristic behavioral disturbances in PWS include excessive interest in food, skin picking, difficulty with a change in routine, temper tantrums, obsessive and compulsive behaviors, and mood fluctuations. Individuals with PWS typically have intellectual disabilities (borderline to mild/moderate mental retardation) and exhibit a higher overall behavior disturbance compared to individuals with similar intellectual disability. Due to its multisystem disorder, family members, caregivers, physicians, dieticians, and speech-language pathologists all play an important role in the management and treatment of symptoms in an individual with PWS. This article reviews current research on behavior and cognition in PWS and discusses management guidelines for this disorder.

摘要

普拉德-威利综合征(PWS)是一种复杂的神经发育障碍,由 15 号染色体长臂(q11-q13)的异常引起,导致多种表型特征,主要表现为食欲过盛和无法满足的食欲。PWS 的典型行为障碍包括对食物过度关注、皮肤搔抓、难以适应常规变化、发脾气、强迫和强迫行为以及情绪波动。患有 PWS 的个体通常存在智力障碍(边缘型至轻度/中度智力障碍),并且与具有相似智力障碍的个体相比,表现出更高的整体行为障碍。由于其多系统障碍,家庭成员、照顾者、医生、营养师和言语语言病理学家在个体 PWS 的症状管理和治疗中都发挥着重要作用。本文综述了 PWS 行为和认知的当前研究,并讨论了该障碍的管理指南。

相似文献

1
Clinical management of behavioral characteristics of Prader-Willi syndrome.
Neuropsychiatr Dis Treat. 2010 May 6;6:107-18. doi: 10.2147/ndt.s5560.
3
An open-label pilot study of N-acetylcysteine for skin-picking in Prader-Willi syndrome.
Am J Med Genet A. 2014 Feb;164A(2):421-4. doi: 10.1002/ajmg.a.36306. Epub 2013 Dec 5.
4
Psychiatric disorders in Prader-Willi syndrome: epidemiology and management.
CNS Drugs. 2003;17(3):167-78. doi: 10.2165/00023210-200317030-00003.
5
Prader-Willi syndrome and autism spectrum disorders: an evolving story.
J Neurodev Disord. 2011 Sep;3(3):225-37. doi: 10.1007/s11689-011-9092-5. Epub 2011 Aug 20.
7
Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome.
Am J Med Genet B Neuropsychiatr Genet. 2016 Mar;171B(2):266-75. doi: 10.1002/ajmg.b.32401. Epub 2015 Nov 21.
9
Reduced gamma-aminobutyric acid is associated with emotional and behavioral problems in Prader-Willi syndrome.
Am J Med Genet B Neuropsychiatr Genet. 2016 Dec;171(8):1041-1048. doi: 10.1002/ajmg.b.32472. Epub 2016 Jun 24.
10
Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.
Neurosci Biobehav Rev. 2015 Dec;59:155-72. doi: 10.1016/j.neubiorev.2015.10.003. Epub 2015 Oct 22.

引用本文的文献

1
Prader-Willi syndrome: guidance for children and transition into adulthood.
Endocr Connect. 2024 Jul 10;13(8). doi: 10.1530/EC-24-0091. Print 2024 Aug 1.
3
Progress in Brain Magnetic Resonance Imaging of Individuals with Prader-Willi Syndrome.
J Clin Med. 2023 Jan 29;12(3):1054. doi: 10.3390/jcm12031054.
4
Aripiprazole treatment for temper outbursts in Prader-Willi syndrome.
Orphanet J Rare Dis. 2022 Aug 26;17(1):324. doi: 10.1186/s13023-022-02470-y.
5
Biological, Behavioral, and Ethical Considerations of Prader-Willi Syndrome: A Primer for Behavior Analysts.
Behav Anal Pract. 2021 Jul 8;15(2):562-570. doi: 10.1007/s40617-021-00618-z. eCollection 2022 Jun.
6
The Efficacy, Safety, and Pharmacology of a Ghrelin O-Acyltransferase Inhibitor for the Treatment of Prader-Willi Syndrome.
J Clin Endocrinol Metab. 2022 May 17;107(6):e2373-e2380. doi: 10.1210/clinem/dgac105.
7
Diagnosis and management of sleep disorders in Prader-Willi syndrome.
J Clin Sleep Med. 2022 Jun 1;18(6):1687-1696. doi: 10.5664/jcsm.9938.
8
Development and validation of the Pediatric-Youth Hyperphagia Assessment for Prader-Willi syndrome.
Epidemiol Health. 2022;44:e2022014. doi: 10.4178/epih.e2022014. Epub 2022 Jan 10.
9
Twenty Years of GH Treatment in Adults with Prader-Willi Syndrome.
J Clin Med. 2021 Jun 17;10(12):2667. doi: 10.3390/jcm10122667.

本文引用的文献

1
Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
J Clin Endocrinol Metab. 2009 Nov;94(11):4205-15. doi: 10.1210/jc.2009-0454. Epub 2009 Oct 16.
3
Dorsal and ventral stream mediated visual processing in genetic subtypes of Prader-Willi syndrome.
Neuropsychologia. 2009 Oct;47(12):2367-73. doi: 10.1016/j.neuropsychologia.2008.09.019. Epub 2008 Oct 4.
4
Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome: a ten-year follow-up.
J Pediatr Endocrinol Metab. 2008 Jul;21(7):651-5. doi: 10.1515/JPEM.2008.21.7.651.
7
Behavior in Prader-Willi syndrome: relationship to genetic subtypes and age.
J Child Psychol Psychiatry. 2008 Sep;49(9):1001-8. doi: 10.1111/j.1469-7610.2008.01913.x. Epub 2008 Jul 28.
8
The relationship between sources and functions of social support and dimensions of child- and parent-related stress.
J Intellect Disabil Res. 2008 Dec;52(12):1138-54. doi: 10.1111/j.1365-2788.2008.01073.x. Epub 2008 May 27.
9
SSRI adverse events: how to monitor and manage.
Int Rev Psychiatry. 2008 Apr;20(2):203-8. doi: 10.1080/09540260801889211.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验